Innovation and Technology Management
Cedars-Sinai Medical Center is an academic center committed to expanding the horizons of medical knowledge through biomedical research. The Medical Center is committed to bringing the discoveries made in its research laboratories to the market so that the public can benefit from the scientific advances made by our faculty.
Through Cedars-Sinai's Burns and Allen Research Institute more than 600 research projects are underway. Overall research funding totals nearly $50 million, of which slightly less than half is from the National Institutes of Health (NIH).
The Medical Center has a great appreciation for the value of intellectual property and has received significant amounts in royalty revenues. These revenues are split among reinvestments in further research and individual inventors.
In 1998, the Medical Center began the Innovation Management and Technology Transfer Program (IMTT) to provide assistance to researchers and inventors with the development of institutional policies and procedures to its CEE partners laying the foundation for the management of their scientific and intellectual assets in a professional manner. This program was originally implemented with three medical universities in Hungary and expanded throughout Central and East Europe.
In 2000 CSMC signed the first Research and Innovation Management bilateral agreements with four Hungarian Medical Universities (Semmelweis in Budapest, Debrecen, Pecs and Szeged). With those Universities CSMC started the Innovation Management and Technology Transfer training program.
In fall of 2003, the Medical Center, along with the Fogarty International Center at the National Institutes of Health, hosted the "Bridges in Life Sciences" symposium in Budapest, presenting topics such as grantsmanship, innovation management, research collaborations and networking to participants from over 10 countries. During the last three years the Bridges in Life Sciences meeting concept has been presented all over CEE in academic and research institutions in Bulgaria, Croatia, Czech Republic, Hungary, Lithuania, Poland, Romania, Slovakia, Slovenia and Ukraine with great success and emphasizing the notion that research has no borders.
In 2004 based on the demand of the potential partners from Bulgaria, Croatia, the Czech Republic, Lithuania, Romania, Slovakia, Slovenia and Ukraine, CSMC - together with NIH - organized several regional IMTT Workshops.
In 2004 and 2005 CSMC signed the Research and Innovation Management bilateral agreements with Bratislava (Slovakia), Bucharest (Romania), Hradec Kralove (Czech Republic), and with Ukrainian organizations (IMBG and Palladin Kyiv, ICB and LNMU in Kyiv) and expanded its Innovation Management and Technology Transfer "Triple I" (Introduce, Involve and Implement) training and implementation program. At the same time, CSMC outlined a Research and Innovation Management Implementation Plan for each partner, started the SWOT Analysis and introduced the Intellectual Property Inventory questionnaire.
In 2004 Cedars-Sinai Medical Center developed a research and innovation management capacity building program for the partner organizations from CEE. Based on the existing knowledge and infrastructure of partner organizations, Cedars-Sinai helped them to implement their infrastructure in three phases:
Phase I: Capacity Building in Innovation Management and Technology Transfer (IMTT)
Phase II: Research, Innovation Management Education and Training Program and Strategic Alliance for Joint Patent Portfolio Management
Phase III: Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium
In March 2005 CSMC decided to move to the next level and the created a regional Consortium based on the bilateral agreements with 11 partners.
Partners of the RECOOP HST Consortium:
- Cedars - Sinai Medical Center, Los Angeles, USA
- Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic
- School of Medicine University J. J. Strossmayer Osijek, Croatia
- University of Debrecen, Hungary
- University of Pecs, Hungary
- University of Szeged, Hungary
- Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
- Slovak Medical University, Bratislava, Slovakia
- Institute of Molecular Biology and Genetics, National Academy of Science of Ukraine, Kyiv, Ukraine
- Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine
- Institute of Cell Biology, National Academy of Sciences of Ukraine, Lviv, Ukraine
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium seeks to create a Strategic Alliance among it¿s the partner organizations and Cedars-Sinai Medical Center ("CSMC"). The Alliance is grounded in the high quality scientific output of the individual Partners as measured by the number of peer-reviewed journal articles, the impact factors and the citation indices. The ongoing purpose of the Alliance is to increase the research capacity of the Consortium Partners, enable expanded biomedical research and provide a means of introducing new sciences to the Consortium market.
The Consortium is looking for potential revenues to enable high quality research, which provides the basis for further innovations. With the guidance of CSMC the Consortium is building a business plan and a business model for Science and Technology. The Consortium is willing to enhance the success rate by licensing intellectual property (IP) to the industry by building a joint patent portfolio and creating a Patent Warehouse. Partners are organizing Research and Innovation Management Summer Schools and regional workshops for other organizations in their countries and the region to create business opportunities in training. The Consortium is building an inventory of research tools (cell lines, test kits, antibodies, markers) created by the participating partners and placing those tools into a Research Tool Warehouse, packaging into research tool boxes. The partners of the Consortium will use those research tools internally to increase the research output of each participating organization, also will be marketed to the external (i.e., nonparticipating) research community and industry. The Consortium is building Multidisciplinary Research Networks to enhance the competitiveness of the participating academic organizations attracting sponsored research and creating of a Joint Clinical Trial Management (JCTM) team will provide business opportunities in Phase III (multi-ethnic, multi-center) clinical trials.